Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports
Authors
Keywords
Drug-induced QTc interval prolongation, Risk factors, Risperidone, <em class=EmphasisTypeItalic >Torsade de pointes</em>
Journal
PSYCHOPHARMACOLOGY
Volume 228, Issue 4, Pages 515-524
Publisher
Springer Nature
Online
2013-06-29
DOI
10.1007/s00213-013-3192-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacogenetics of Risperidone: A Systematic Review of the Clinical Effects of CYP2D6 Polymorphisms
- (2013) Andrea L Cartwright et al. ANNALS OF PHARMACOTHERAPY
- Citalopram, QTc Interval Prolongation, and Torsade de Pointes. How Should We Apply the Recent FDA Ruling?
- (2012) W. Victor R. Vieweg et al. AMERICAN JOURNAL OF MEDICINE
- Selective acquired long QT syndrome (saLQTS) upon risperidone treatment
- (2012) Maciej Jakub Lazarczyk et al. BMC Psychiatry
- Antipsychotic drugs are associated with pulseless electrical activity: The Oregon Sudden Unexpected Death Study
- (2012) Carmen Teodorescu et al. HEART RHYTHM
- Prolonged Tpeak-to-Tend Interval on the Resting ECG Is Associated With Increased Risk of Sudden Cardiac Death
- (2011) Ragesh Panikkath et al. Circulation-Arrhythmia and Electrophysiology
- Acquired Long QT Interval: A Case Series of Multifactorial QT Prolongation
- (2011) Geneviève C. Digby et al. CLINICAL CARDIOLOGY
- Prolongation of Cardiac Ventricular Repolarization Under Paliperidone: How and How Much?
- (2011) Patrick Vigneault et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Risperidone-Induced QT Prolongation Following Overdose Correlates With Serum Drug Concentration and Resolves Rapidly With No Evidence of Altered Pharmacokinetics
- (2010) P. Timothy Pollak et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Proarrhythmic Risk with Antipsychotic and Antidepressant Drugs
- (2009) W. Victor R. Vieweg et al. DRUGS & AGING
- Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS)
- (2009) Elisabetta Poluzzi et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Temperament and character among Korean children and adolescents with anxiety disorders
- (2008) Soo-churl Cho et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Accurate electrocardiographic assessment of the QT interval: Teach the tangent
- (2008) Pieter G. Postema et al. HEART RHYTHM
- Concomitant-Acquired Long QT and Brugada Syndromes Associated with Indapamide-Induced Hypokalemia and Hyponatremia
- (2008) NGAI-SHING MOK et al. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- Preclinical Torsades-de-Pointes Screens: Advantages and limitations of surrogate and direct approaches in evaluating proarrhythmic risk
- (2008) Gary A. Gintant PHARMACOLOGY & THERAPEUTICS
- The hERG potassium channel and hERG screening for drug-induced torsades de pointes
- (2008) Jules C. Hancox et al. PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started